Joint Health

Millions of people, and especially those with aging joints, are looking for products that can help them keep moving in order to enjoy a good quality of life.

Marine Omega-3 fatty acids have been shown to provide nutritional support to help keep the cartilage between the joints healthy. More specifically, it is the fatty acid EPA that has been clinically proven to help maintain day-to-day mobility. EPA supplementation was found especially beneficial for those people with morning joint stiffness.

A formula based on numerous clinical trials,
EPAX 4510 TG has been designed to deliver high levels of concentrated EPA in order to provide nutrition to joints, help reduce stiffness, and support mobility.


 Click here to see articles about Omega-3 and Joint Health
 
 

EPAX 4510 TG

390 mg/g EPA
70 mg/g DHA

EPAX 4510 TG Specification
EPAX 4510 TG Nutritional values
 
 
EPAX News & Events

Epax phase-3 study builds base for continued expansion into pharmaceutical omega-3 segment

Epax AS continues expansion into the pharmaceutical omega-3 segment with study
on AKR963 successfully achieving phase 3 study efficacy endpoints.

Read Press Release

 
 

EPAX Announces Corporate Restructuring

The Omega-3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the Epax group.

Read press release

 
 

EPAX again honored as top supplier by Banner Pharmacaps.

EPAX AS was recognized for on-time deliveries and high quality standards.

Read press release

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com